4.8 Review

Mast cell: an emerging partner in immune interaction

期刊

FRONTIERS IN IMMUNOLOGY
卷 3, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2012.00120

关键词

mast cell; cell-cell interaction; adaptive immunity; innate immunity

资金

  1. COST Action of the European Community [BM1007]

向作者/读者索取更多资源

Mast cells (MCs) are currently recognized as effector cells in many settings of the immune response, including host defense, immune regulation, allergy, chronic inflammation, and autoimmune diseases. MC pleiotropic functions reflect their ability to secrete a wide spectrum of preformed or newly synthesized biologically active products with pro-inflammatory, anti-inflammatory and/or immunosuppressive properties, in response to multiple signals. Moreover, the modulation of MC effector phenotypes relies on the interaction of a wide variety of membrane molecules involved in cell-cell or cell-extracellular-matrix interaction. The delivery of co-stimulatory signals allows MC to specifically communicate with immune cells belonging to both innate and acquired immunity, as well as with non-immune tissue-specific cell types. This article reviews and discusses the evidence that MC membrane-expressed molecules play a central role in regulating MC priming and activation and in the modulation of innate and adaptive immune response not only against host injury, but also in peripheral tolerance and tumor-surveillance or -escape. The complex expression of MC surface molecules may be regarded as a measure of connectivity, with altered patterns of cell-cell interaction representing functionally distinct MC states. We will focalize our attention on roles and functions of recently discovered molecules involved in the cross-talk of MCs with other immune partners.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

Mast Cells Respond to Candida albicans Infections and Modulate Macrophages Phagocytosis of the Fungus

Marco De Zuani, Giuseppe Paolicelli, Teresa Zelante, Giorgia Renga, Luigina Romani, Alessandra Arzese, Carlo E. M. Pucillo, Barbara Frossi

FRONTIERS IN IMMUNOLOGY (2018)

Letter Allergy

Efficacy of rituximab as a single-agent therapy for the treatment of granulomatous and lymphocytic interstitial lung disease in patients with common variable immunodeficiency

Lorenzo Cereser, Riccardo De Carli, Rossano Girometti, Alessandro De Pellegrin, Federico Reccardini, Barbara Frossi, Marco De Carli

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)

Article Biochemistry & Molecular Biology

Endonuclease and redox activities of human apurinic/apyrimidinic endonuclease 1 have distinctive and essential functions in IgA class switch recombination

Barbara Frossi, Giulia Antoniali, Kefei Yu, Nahid Akhtar, Mark H. Kaplan, Mark R. Kelley, Gianluca Tell, Carlo E. M. Pucillo

JOURNAL OF BIOLOGICAL CHEMISTRY (2019)

Article Cell Biology

Frontline Science: Mast cells regulate neutrophil homeostasis by influencing macrophage clearance activity

Elena Jachetti, Federica D'Inca, Luca Danelli, Raffaella Magris, Chiara Dal Secco, Filippo Vit, Valeria Cancila, Claudio Tripodo, Patrizia Scapini, Mario Paolo Colombo, Carlo Pucillo, Barbara Frossi

JOURNAL OF LEUKOCYTE BIOLOGY (2019)

Article Immunology

IL-10-producing B cells are characterized by a specific methylation signature

Silvia Tonon, Francesca Mion, Jun Dong, Hyun-Dong Chang, Emiliano Dalla, Patrizia Scapini, Giuseppe Perruolo, Andrea Zanello, Matteo Dugo, Marco A. Cassatella, Mario P. Colombo, Andreas Radbruch, Claudio Tripodo, Carlo E. Pucillo

EUROPEAN JOURNAL OF IMMUNOLOGY (2019)

Review Biochemistry & Molecular Biology

Coeliac Disease and Mast Cells

Barbara Frossi, Marco De Carli, Antonino Calabro

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Genetics & Heredity

Inhibition of APE1-endonuclease activity affects cell metabolism in colon cancer cells via a p53-dependent pathway

Marta Codrich, Marina Comelli, Matilde Clarissa Malfatti, Catia Mio, Dilara Ayyildiz, Chi Zhang, Mark R. Kelley, Giovanni Terrosu, Carlo Em Pucillo, Gianluca Tell

DNA REPAIR (2019)

Article Immunology

Repurposing of the Antiepileptic Drug Levetiracetam to Restrain Neuroendocrine Prostate Cancer and Inhibit Mast Cell Support to Adenocarcinoma

Roberta Sulsenti, Barbara Frossi, Lucia Bongiovanni, Valeria Cancila, Paola Ostano, Irene Fischetti, Claudia Enriquez, Francesca Guana, Giovanna Chiorino, Claudio Tripodo, Carlo E. Pucillo, Mario P. Colombo, Elena Jachetti

Summary: Levetiracetam has the potential to be an effective drug for the treatment of prostate cancer by targeting both MCs and NEPC cells. Experimental results demonstrate that levetiracetam can directly inhibit NEPC development and block adenocarcinoma progression through the inhibition of some MCs functions.

FRONTIERS IN IMMUNOLOGY (2021)

Article Immunology

LPS Guides Distinct Patterns of Training and Tolerance in Mast Cells

Marco De Zuani, Chiara Dal Secco, Silvia Tonon, Alessandra Arzese, Carlo E. M. Pucillo, Barbara Frossi

Summary: Mast cells are important innate immune cells that can sense and respond to different stimuli. Studies have shown that mast cells can develop immunological memory, and their responses can be shaped by different stimulatory environments.

FRONTIERS IN IMMUNOLOGY (2022)

Article Biochemistry & Molecular Biology

Combining Deep Phenotyping of Serum Proteomics and Clinical Data via Machine Learning for COVID-19 Biomarker Discovery

Antonio Paolo Beltrami, Maria De Martino, Emiliano Dalla, Matilde Clarissa Malfatti, Federica Caponnetto, Marta Codrich, Daniele Stefanizzi, Martina Fabris, Emanuela Sozio, Federica D'Aurizio, Carlo E. M. Pucillo, Leonardo A. Sechi, Carlo Tascini, Francesco Curcio, Gian Luca Foresti, Claudio Piciarelli, Axel De Nardin, Gianluca Tell, Miriam Isola

Summary: This study identified nine potential serum biomarkers for predicting the severity of COVID-19 by analyzing serum proteins and clinical data. Three of these biomarkers were associated with central nervous system pathologies and protective factors, and were downregulated in the most severe cases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Allergy

Mechanism and clinical evidence of immunotherapy in allergic rhinitis

Marco De Carli, Eleonora Capezzali, Silvia Tonon, Barbara Frossi

Summary: Allergic rhinitis is an upper airway disease caused by hypersensitivity to aeroallergens, and it can lead to increased inflammation throughout the body. Immunotherapy is a possible treatment approach to reduce the use of antihistamines and corticosteroids. It has been shown to prevent new sensitizations and reduce the risk of developing asthma in patients with allergic rhinitis, but its effectiveness in reducing symptom severity and relapse is still debated. This review focuses on the impact of sexual dimorphism on disease manifestation and the efficacy of allergen-specific immunotherapy.

FRONTIERS IN ALLERGY (2023)

Meeting Abstract Immunology

The protective role of mast cells against neuroendocrine prostate cancer depends on the release of cytokines mediated by intracellular osteopontin

Roberta Sulsenti, Valeria Cancila, Claudia Enriquez, Barbara Frossi, Renata Ferri, Laura Botti, Claudia Chiodoni, Carlo E. Pucillo, Claudio Tripodo, Mario P. Colombo, Elena Jachetti

EUROPEAN JOURNAL OF IMMUNOLOGY (2021)

暂无数据